{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:35:20Z","timestamp":1788543320684,"version":"build-2803163510"},"reference-count":136,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.tcm.2018.06.011","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T12:55:43Z","timestamp":1530190543000},"page":"83-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cardiovascular magnetic resonance imaging for amyloidosis: The state-of-the-art"],"prefix":"10.1016","volume":"29","author":[{"given":"Chun Xiang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen E.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir M.","family":"Sanghvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Jiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2018.06.011_bib0001","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1148\/rg.2015140179","article-title":"Amyloidosis: modern cross-sectional imaging","volume":"35","author":"Czeyda-Pommersheim","year":"2015","journal-title":"Radiographics"},{"key":"10.1016\/j.tcm.2018.06.011_bib0002","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1200\/JCO.2015.62.4015","article-title":"Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a center for international blood and marrow transplant research study","volume":"33","author":"D'Souza","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0003","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-CA: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Casta\u00f1o","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.tcm.2018.06.011_bib0004","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/blood-2016-11-751628","article-title":"Improved outcomes for newly diagnosed AL amyloidosis over the years 2000 and 2014: cracking the glass ceiling of early death","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2018.06.011_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0006","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0007","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulatio"},{"key":"10.1016\/j.tcm.2018.06.011_bib0008","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/eurheartj\/ehx210","article-title":"Challenging the myths of cardiac amyloidosis","volume":"38","author":"Siddiqi","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2018.06.011_bib0009","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2018.06.011_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2016-01-629790","article-title":"What is new in diagnosis and management of light chain amyloidosis?","volume":"128","author":"Palladini","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2018.06.011_bib0011","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.acvd.2013.06.051","article-title":"Cardiac amyloidosis: updates in diagnosis and management","volume":"106","author":"Mohty","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.tcm.2018.06.011_bib0012","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/00015385.2017.1335034","article-title":"Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options","volume":"72","author":"Alkhawam","year":"2017","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0013","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcmg.2014.03.004","article-title":"Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy","volume":"7","author":"Longhi","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0014","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/ehjci\/jew101","article-title":"Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis","volume":"17","author":"Bhatti","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCIMAGING.113.001396","article-title":"How to image cardiac amyloidosis","volume":"7","author":"Falk","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0016","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2018.06.011_bib0017","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrcardio.2014.165","article-title":"Pathophysiology and treatment of cardiac amyloidosis","volume":"12","author":"Gertz","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0018","article-title":"Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles","author":"Knight","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-014-9470-7","article-title":"Cardiovascular magnetic resonance for amyloidosis","volume":"20","author":"Fontana","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.tcm.2018.06.011_bib0020","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jcmg.2015.07.004","article-title":"Cardiac imaging to evaluate left ventricular diastolic function","volume":"8","author":"Flachskampf","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1532-429X-16-30","article-title":"Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE study","volume":"16","author":"Wollmann","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0022","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.hrthm.2015.02.010","article-title":"Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions","volume":"12","author":"Bailey","year":"2015","journal-title":"Heart Rhythm"},{"issue":"24","key":"10.1016\/j.tcm.2018.06.011_bib0023","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.jacc.2015.04.047","article-title":"Full-body MRI in patients with an implantable cardioverter-defibrillator: primary results of a randomized study","volume":"65","author":"Gold","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0024","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hrthm.2010.10.002","article-title":"Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment","volume":"8","author":"Wilkoff","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2018.06.011_bib0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.hrthm.2017.10.003","article-title":"Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices","volume":"15","author":"Do","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2018.06.011_bib0026","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1161\/CIRCULATIONAHA.107.187256","volume":"116","author":"Levine","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.06.011_bib0027","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1056\/NEJMoa1603265","article-title":"Assessing the risks associated with MRI in patients with a pacemaker or defibrillator","volume":"376","author":"Russo","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2018.06.011_bib0028","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.hrthm.2017.03.039","article-title":"Safety and utility of magnetic resonance imaging in patients with cardiac implantable electronic devices","volume":"14","author":"Strom","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2018.06.011_bib0029","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1586\/14779072.2015.1093936","article-title":"Novel strategies for the diagnosis and treatment of cardiac amyloidosis","volume":"13","author":"Palladini","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.tcm.2018.06.011_bib0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1055\/s-0034-1399546","article-title":"T1, T2 mapping and extracellular volume fraction (ECV): application, value and further perspectives in myocardial inflammation and cardiomyopathies","volume":"187","author":"Roller","year":"2015","journal-title":"Rofo"},{"key":"10.1016\/j.tcm.2018.06.011_bib0031","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.tcm.2018.06.011_bib0032","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0033","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1161\/CIRCULATIONAHA.115.018832","article-title":"Cardiovascular magnetic resonance visualization of cardiac amyloid infiltration: challenges and opportunities","volume":"132","author":"Ruberg","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.06.011_bib0034","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1148\/radiol.11091882","article-title":"Delayed contrast enhancement on MR images of myocardium: past, present, future","volume":"261","author":"Ordovas","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.tcm.2018.06.011_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0036","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/jmri.24715","article-title":"Endogenous contrast MRI of cardiac fibrosis: beyond late gadolinium enhancement","volume":"41","author":"van Oorschot","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0037","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2018.06.011_bib0038","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11912-017-0607-4","article-title":"Cardiac amyloidosis: diagnosis and treatment strategie","volume":"19","author":"Tuzovic","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.tcm.2018.06.011_bib0039","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/RTI.0000000000000270","article-title":"Cardiac magnetic resonance T1-mapping of the myocardium technical background and clinical relevance","volume":"33","author":"Muscogiuri","year":"2018","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijcard.2015.05.155","article-title":"Novel potential therapeutic strategies of senile cardiac amyloidosis: heat shock factor 1 blocks senile cardiac amyloidosis via HSPA1A in mouse model","volume":"195","author":"Qian","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0041","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/cpf.12216","article-title":"The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis","volume":"36","author":"Fikrle","year":"2016","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0042","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12968-016-0297-3","article-title":"Dark blood late enhancement imaging","volume":"18","author":"Kellman","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0043","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mrm.26692","article-title":"Improved dark blood late gadolinium enhancement (DB-LGE) imaging using an optimized jointinversion preparation and T2 magnetization preparation","volume":"79","author":"Basha","year":"2018","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.tcm.2018.06.011_bib0044","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.ejrad.2014.09.014","article-title":"Three-dimensional phase-sensitive inversion recovery sequencing in the evaluation of left ventricular myocardial scars in ischemic and non-ischemic cardiomyopathy: comparison to threedimensional inversion recovery sequencing","volume":"83","author":"Kido","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12968-017-0405-z","article-title":"3D whole-heart phase sensitive inversion recovery CMR for simultaneous black-blood late gadolinium enhancement and bright-blood coronary CMR angiography","volume":"19","author":"Ginami","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0046","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.06.011_bib0047","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.20110","article-title":"Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart","volume":"52","author":"Messroghli","year":"2004","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.tcm.2018.06.011_bib0048","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1532-429X-12-69","article-title":"Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold","volume":"12","author":"Piechnik","year":"2010","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0049","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/mrm.24878","article-title":"Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping","volume":"71","author":"Chow","year":"2014","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.tcm.2018.06.011_bib0050","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/mrm.24761","article-title":"Combined saturation\/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability","volume":"71","author":"Weing\u00e4rtner","year":"2014","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.tcm.2018.06.011_bib0051","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2013.05.078","article-title":"Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"62","author":"Liu","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0052","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0053","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-16-21","article-title":"Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis\u2013a clinical study using myocardial T1-mapping and extracellular volume quantification","volume":"16","author":"Ntusi","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0054","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","article-title":"T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex","volume":"6","author":"Thompson","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1148\/radiol.14140296","article-title":"Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-tohead comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE","volume":"272","author":"Roujol","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.tcm.2018.06.011_bib0056","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcmg.2012.08.019","article-title":"Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy","volume":"6","author":"Puntmann","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0057","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/CIRCIMAGING.112.976738","article-title":"Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy","volume":"5","author":"Dass","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0058","doi-asserted-by":"crossref","first-page":"P5","DOI":"10.1186\/1532-429X-17-S1-P5","article-title":"Variability of T1 in purpose recruited normal volunteers and patients as a function of shim (B0), flip angle (B1) and myocardial sector at 3T","volume":"17","author":"Rao","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0059","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12968-016-0302-x","article-title":"Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI","volume":"18","author":"Weing\u00e4rtner","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ehjci\/jeu183","article-title":"T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy","volume":"16","author":"aus dem Siepen","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0061","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0062","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcmg.2015.10.027","article-title":"LGE provides incremental prognostic information over serum biomarkers in AL cardiac amyloidosis","volume":"9","author":"Boynton","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0063","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.06.011_bib0064","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1532-429X-13-75","article-title":"Myocardial T1 and extracellular volume fraction mapping at 3 tesla","volume":"13","author":"Lee","year":"2011","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1532-429X-15-56","article-title":"T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision","volume":"15","author":"Kellman","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0066","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.06.011_bib0067","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2016.09.953","article-title":"18F-sodium fluoride PET\/MR for the assessment of cardiac amyloidosis","volume":"68","author":"Trivieri","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506121003619310","article-title":"How to diagnose cardiac amyloidosis early: impact of ECG, tissue Doppler echocardiography, and myocardial biopsy","volume":"17","author":"Piper","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.tcm.2018.06.011_bib0069","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCIMAGING.113.000683","article-title":"Effect of combined systolic and diastolic functional param- eter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy","volume":"6","author":"Liu","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0070","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/heartjnl-2015-308657","article-title":"Prognostic implication of relative regional strain ratio in cardiac amyloidosis","volume":"102","author":"Senapati","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2018.06.011_bib0071","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcmg.2016.04.008","article-title":"Prognosis of light chain amyloidosis with preserved LVEF: added value of 2D speckle-tracking echocardiography to the current prognostic staging system","volume":"10","author":"Barros-Gomes","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0072","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ehjci\/jew298","article-title":"Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis","volume":"18","author":"Salinaro","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0073","doi-asserted-by":"crossref","first-page":"W57","DOI":"10.2214\/AJR.16.16982","article-title":"Automated description of regional left ventricular motion in patients with cardiac amyloidosis: a quantitative study using heart deformation analysis","volume":"209","author":"Meng","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0074","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretinrelated versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.06.011_bib0075","first-page":"159","article-title":"Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis systemic hypertension and normal left ventricular mass","volume":"31","author":"Cappelli","year":"2011","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0076","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1253\/circj.CJ-16-1259","article-title":"Identification and assessment of cardiac amyloidosis by myocardial strain analysis of cardiac magnetic resonance imaging","volume":"81","author":"Oda","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.tcm.2018.06.011_bib0077","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/jmri.25678","article-title":"Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis","volume":"46","author":"Arani","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"sup1","key":"10.1016\/j.tcm.2018.06.011_bib0078","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/13506129.2017.1278689","article-title":"Feasibility study of cardiac magnetic resonance elastography in cardiac amyloidosis","volume":"24","author":"Chang","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.tcm.2018.06.011_bib0079","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.06.011_bib0080","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2018.06.011_bib0081","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12968-016-0240-7","article-title":"Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance","volume":"18","author":"Li","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0082","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1038\/s41598-017-03699-5","article-title":"Myocardial deformation in cardiac amyloid light-chain amyloidosis: assessed with 3T cardiovascular magnetic resonance feature tracking","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tcm.2018.06.011_bib0083","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.tcm.2018.06.011_bib0084","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0085","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1136\/heartjnl-2014-305710","article-title":"Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis","volume":"100","author":"Pozo","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2018.06.011_bib0086","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.amjcard.2014.02.030","article-title":"Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis","volume":"113","author":"Fine","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0087","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13506129.2017.1333956","article-title":"Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis","volume":"24","author":"Cariou","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.tcm.2018.06.011_bib0088","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.amjcard.2015.05.021","article-title":"Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function","volume":"116","author":"Kwong","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0089","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/13506129.2014.956924","article-title":"Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study","volume":"21","author":"Deux","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.tcm.2018.06.011_bib0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-14-42","article-title":"Non contrast T1 mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance","volume":"14","author":"Ferreira","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0091","doi-asserted-by":"crossref","unstructured":"Ruberg FL. T1 mapping in cardiac amyloidosis: can we get there from here? J Am Coll Cardiol Img 2013;6:498\u2013500.","DOI":"10.1016\/j.jcmg.2013.01.007"},{"key":"10.1016\/j.tcm.2018.06.011_bib0092","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1007\/s00330-017-4845-5","article-title":"Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy","volume":"27","author":"Oda","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0093","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11912-017-0607-4","article-title":"Cardiac amyloidosis: diagnosis and treatment strategie","volume":"19","author":"Tuzovic","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.tcm.2018.06.011_bib0094","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/heartjnl-2012-302346","article-title":"Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease","volume":"98","author":"Sado","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2018.06.011_bib0095","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/joim.12324","article-title":"Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging","volume":"277","author":"Barison","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.tcm.2018.06.011_bib0096","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"Suppl 1","key":"10.1016\/j.tcm.2018.06.011_bib0097","doi-asserted-by":"crossref","first-page":"P341","DOI":"10.1186\/1532-429X-16-S1-P341","article-title":"AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology","volume":"16","author":"Fontana","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2018.06.011_bib0098","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/leu.2016.191","article-title":"Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis","volume":"30","author":"Merlini","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.tcm.2018.06.011_bib0099","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal probrain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0101","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0102","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/heartjnl-2013-304957","article-title":"High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis","volume":"100","author":"Dispenzieri","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2018.06.011_bib0103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4065\/mcp.2010.0480","article-title":"Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score","volume":"86","author":"Kumar","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2018.06.011_bib0104","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0105","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ehjci\/jes009","article-title":"Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study","volume":"13","author":"Bellavia","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0106","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jcmg.2014.03.002","article-title":"Noninvasive risk stratification of patients with transthyretin amyloidosis","volume":"7","author":"Kristen","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0107","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2018.06.011_bib0108","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/anec.12036","article-title":"Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis","volume":"18","author":"Mussinelli","year":"2013","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0109","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2012.04.043","article-title":"Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers","volume":"60","author":"Buss","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0110","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejheart.2007.05.006","article-title":"Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis","volume":"9","author":"Ghio","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2018.06.011_bib0111","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood-2010-02-267708","article-title":"Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay","volume":"116","author":"Kristen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2018.06.011_bib0112","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","article-title":"CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis","volume":"7","author":"White","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0113","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2018.06.011_bib0114","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1148\/rg.2017160082","article-title":"Radiologic-pathologic correlation of primary and secondary cardiomyopathies: MR imaging and histopathologic findings in hearts from autopsy and transplantation","volume":"37","author":"Hashimura","year":"2017","journal-title":"Radiographics"},{"key":"10.1016\/j.tcm.2018.06.011_bib0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurheartj\/ehs188","article-title":"Left atrial structure and function and clinical outcomes in the general population","volume":"34","author":"Gupta","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2018.06.011_bib0116","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ehjci\/jew100","article-title":"Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study","volume":"17","author":"Mohty","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0117","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1161\/CIRCULATIONAHA.114.009135","article-title":"Regression of cardiac amyloidosis after stem cell transplantation assessed by cardiovascular magnetic resonance imaging","volume":"129","author":"Brahmanandam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.06.011_bib0118","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00392-015-0826-3","article-title":"Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study","volume":"104","author":"aus dem Siepen","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0119","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.004770","article-title":"Serial native T1 mapping to monitor cardiac response to treatment in light-chain amyloidosis","volume":"9","author":"Hur","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0120","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1681\/ASN.2016060686","article-title":"Intradialytic cardiac magnetic resonance imaging to assess cardiovascular responses in a short-term trial of hemodiafiltration and hemodialysis","volume":"28","author":"Buchanan","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0121","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1200\/JCO.2015.63.6530","article-title":"First-in-human phase I\/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction","volume":"34","author":"Gertz","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tcm.2018.06.011_bib0122","unstructured":"Chenchu Xu, Lei Xu, Zhifan Gao, Shen zhao, Heye Zhang, et\u00a0al. Direct detection of pixel-level myocardial infarction areas via a deep-learning algorithm. 2017, arXiv:1706.03182 [cs.CV]"},{"key":"10.1016\/j.tcm.2018.06.011_bib0123","doi-asserted-by":"crossref","first-page":"38","DOI":"10.21037\/qims.2017.02.05","article-title":"Myocardial strain and symptom severity in severe aortic stenosis: insights from cardiovascular magnetic resonance","volume":"7","author":"Al Musa","year":"2017","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.tcm.2018.06.011_bib0124","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10741-018-9684-1","article-title":"Imaging technologies for cardiac fiber and heart failure: a review","volume":"23","author":"Watson","year":"2018","journal-title":"Heart Fail Rev"},{"issue":"114","key":"10.1016\/j.tcm.2018.06.011_bib0125","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/CIRCULATIONAHA.105.545863","article-title":"Diffusion tensor magnetic resonance imaging mapping the fiber architecture remodeling in human myocardium after infarction: correlation with viability and wall motion","volume":"5","author":"Wu","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2018.06.011_bib0126","first-page":"9","article-title":"Studying dynamic myofiber aggregate reorientation in dilated cardiomyopathy using In vivo magnetic resonance diffusion tensor imaging","author":"von Deuster","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2018.06.011_bib0127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0329-8","article-title":"Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-\u03b2-induced pathology","volume":"10","author":"Praet","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tcm.2018.06.011_bib0128","article-title":"Global white matter diffusion characteristics predict longitudinal cognitive change independently of amyloid status in clinically normal older adults","author":"Rabin","year":"2018","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.tcm.2018.06.011_bib0129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuroscience.2014.02.017","article-title":"Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment","volume":"276","author":"Amlien","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.tcm.2018.06.011_bib0130","doi-asserted-by":"crossref","first-page":"e12894","DOI":"10.14814\/phy2.12894","article-title":"Microstructural characterization of myocardial infarction with optical coherence tractography and two-photon microscopy","volume":"4","author":"Goergen","year":"2016","journal-title":"Physiol Rep"},{"key":"10.1016\/j.tcm.2018.06.011_bib0131","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1148\/radiol.2016152613","article-title":"Diffusion tractography of the entire left ventricle by using free-breathing accelerated simultaneous multisection imaging","volume":"282","author":"Mekkaoui","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.tcm.2018.06.011_bib0132","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/mrm.25784","article-title":"Second-order motioncompensated spin echo diffusion tensor imaging of the human heart","volume":"75","author":"Stoeck","year":"2016","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.tcm.2018.06.011_bib0133","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.1128635","article-title":"Prion-induced amyloid heart disease with high blood infectivity in transgenic mice","volume":"313","author":"Trifilo","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tcm.2018.06.011_bib0134","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1182\/blood-2011-04-351643","article-title":"Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis","volume":"118","author":"Ward","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2018.06.011_bib0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/labinvest.2011.195","article-title":"Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: a valid pathological model of the human disease","volume":"92","author":"Ueda","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.tcm.2018.06.011_bib0136","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijcard.2015.05.155","article-title":"Novel potential therapeutic strategies of senile cardiac amyloidosis: heat shock factor 1 blocks senile cardiac amyloidosis via HSPA1A in mouse model","volume":"195","author":"Qian","year":"2015","journal-title":"Int J Cardiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173818301154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173818301154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T05:14:14Z","timestamp":1717305254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173818301154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1050173818301154"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2018.06.011","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular magnetic resonance imaging for amyloidosis: The state-of-the-art","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2018.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}